ArticleImmunotherapy advances2021

Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cells.

Gessa Sugiyarto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.